- Delivering Pan India
Remicade® (Infliximab) Infliximab 100 mg lyophilised powder for injection by Janssen (Johnson & Johnson). Genuine stock supplied in bulk/wholesale quantities to hospitals and pharmacies across India by A.K. Pharma, a licensed pharmaceutical distributor in Delhi.
| Composition | Infliximab 100 mg |
|---|---|
| Manufacturer | Janssen (Johnson & Johnson) |
| Country | Belgium |
| Pack size | 1 vial |
| Storage | Store refrigerated at 2°C to 8°C in the original carton, as stated on the label |
Supplied only against a valid prescription from a registered medical practitioner.
Sourced from authorised channels
Temperature-controlled packing
Hospitals, clinics, pharmacies
Delhi drug licence holder
Remicade® (Infliximab) 100 mg Lyophilised Powder for Injection: A Sourcing Guide for Hospitals and Pharmacies
Remicade® is an infliximab product (anti-TNF monoclonal antibody) marketed by Janssen, a Johnson & Johnson company. The decision to prescribe infliximab, including patient selection, dose and monitoring, rests entirely with the treating physician. This page provides sourcing and procurement information for hospitals and pharmacies, not clinical or treatment guidance.
As both a trusted medicine distributor in Delhi and a licensed pharmaceutical distributor in Delhi, A.K. Pharma supplies genuine Remicade® (infliximab) 100 mg lyophilised powder for injection to hospitals and pharmacies across India. Buyers comparing pharmaceutical distribution companies and wholesale pharmaceutical distributors can also browse our full product range and the Immunosuppressant category. Supply is in bulk/wholesale quantities only.
Remicade contains infliximab, a chimeric monoclonal antibody supplied as a lyophilised powder in a single-dose 100 mg vial that is reconstituted for intravenous infusion by healthcare professionals. Indications and use in India are those printed in the Indian pack insert.
How it works, according to the label: The US prescribing information (DailyMed) describes infliximab as a tumour necrosis factor (TNF) blocker.
The current US prescribing information for Remicade (DailyMed) lists the following. Indications in India may differ and are defined by the Indian regulator and the Remicade pack insert.
Published studies of infliximab include ATTRACT (Lancet 1999) in rheumatoid arthritis, ACCENT I (Lancet 2002) in Crohn’s disease, ACT 1 and ACT 2 (N Engl J Med 2005) in ulcerative colitis and SONIC (N Engl J Med 2010) in Crohn’s disease. Results and conclusions are those of the trial authors and the prescribing information; A.K. Pharma does not interpret them.
| Strength | Dosage form | Pack (confirm against the carton) |
|---|---|---|
| Infliximab 100 mg | Lyophilised powder for intravenous infusion | Single-dose vial (confirm against the carton) |
Please confirm the current pack and batch with us before ordering. Dose and regimen must be determined and followed exactly as directed by the treating physician and the approved prescribing information.
Hospitals, gastroenterology and rheumatology centres, infusion centres and pharmacies in India that need to source Remicade in bulk quantities from a licensed distributor.
Side effects are listed in the prescribing information and Indian pack insert and are not summarised here. The US label carries a boxed warning on serious infections and malignancy; refer to the label and consult the treating physician.
All use should follow the approved prescribing information and the instructions of the treating physician.
Store refrigerated at 2°C to 8°C in the original carton, protected from light, as directed on the pack. Check the carton for any permitted storage excursions.
Remicade is marketed by Janssen, a Johnson & Johnson company. A.K. Pharma is a licensed distributor and does not manufacture the product. As one of the pharmaceutical distributors serving Indian hospitals, we source Remicade through authorised channels and supply it with pack and batch details. Buyers comparing a pharmaceutical wholesale distributors list or a pharma distribution company can verify our credentials on the About Us page.
Is Remicade available in India?
A.K. Pharma supplies Remicade® (infliximab) 100 mg lyophilised powder for injection to hospitals and pharmacies in India. Contact us for current availability.
What does Remicade contain?
Remicade contains infliximab, marketed by Janssen (Johnson & Johnson). The details of use are those on its label.
Can I order a single pack?
A.K. Pharma is a distributor and supplies bulk/wholesale quantities only, not one or two pieces.
How should Remicade be stored?
The label directs refrigerated storage at 2°C to 8°C. Check the carton for the exact instructions.
Is Remicade a biologic?
Yes. It is an infliximab monoclonal antibody product, so cold-chain handling applies.
Does A.K. Pharma advise on dosing or suitability?
No. Treatment decisions, including dosing, rest solely with the treating physician and the approved prescribing information.
How do I request a quote?
Call or WhatsApp us, or use the contact details below.
📍 E-2/257A, 2nd Floor, Shastri Nagar, New Delhi 110052
📞 011 4172 6999
📱 WhatsApp: +91 9810034827
🌐 akpharma.in
Disclaimer: This page is intended for informational and sourcing/procurement purposes only and does not constitute medical or clinical advice. A.K. Pharma is a licensed medicine distributor, not a healthcare provider, and does not provide clinical guidance. All treatment decisions, including drug selection and dosing, rest solely with the treating physician and should follow the approved prescribing information.
